• Resiniferatoxin (RTX): Precision Analgesia via TRPV1 Inactiv

  2026-07-18

  Explore the science of Resiniferatoxin (RTX) as a precision analgesic targeting TRPV1 channels, with unique insights into its mechanism, dosing, and clinical promise. This article goes beyond protocols to reveal RTX's transformative impact on pain and inflammation research.

• Allosteric Biosensors Enable Native Protein Tracking in Live

  2026-07-17

  This study introduces a genetically encoded, allosteric biosensor system (circStep) for spatiotemporal visualization of endogenous protein dynamics in living cells, avoiding the artifacts of overexpression or genome editing. The platform provides a high-fidelity means to track native protein localization and abundance, with applications in drug screening and mechanistic cell biology.

• Berberrubine Modulates Vitamin K Cycle to Inhibit Thrombosis

  2026-07-17

  This study reveals that berberrubine, a principal metabolite of berberine, inhibits thrombosis in mice by targeting the vitamin K catalytic cycle, as demonstrated by integrated metabolomics and molecular docking. The findings offer mechanistic insight into safer antithrombotic drug development and highlight distinct regulatory effects compared to conventional anticoagulants.

• Proteoform-Specific Drug Interactions in Native Membrane Sys

  2026-07-16

  This study introduces a native mass spectrometry workflow allowing direct sequencing and analysis of proteoforms—including post-translationally modified and alternatively spliced forms—within intact lipid bilayers. The findings reveal that PDE5 inhibitors such as vardenafil show proteoform- and context-specific off-target binding to retinal PDE6, underscoring the importance of native environment profiling for precision drug development.

• Nicotine Signaling Drives Chronic Kidney Disease Progression

  2026-07-16

  Jain and Jaimes' review synthesizes clinical and experimental data implicating nicotine, via non-neuronal nicotinic acetylcholine receptors (nAChRs) and oxidative stress, as a mechanistic driver of chronic kidney disease (CKD) progression in smokers. These insights clarify how nicotine-induced pathways accelerate renal injury and suggest future research directions targeting oxidative and fibrotic mechanisms implicated in CKD.

• Dihydroartemisinin: Applied Workflows for Malaria and mTOR R

  2026-07-15

  Dihydroartemisinin, a potent Artemisia plant extract, excels as a malaria research chemical and mTOR signaling pathway inhibitor. This article details how to optimize experimental design, maximize reproducibility, and troubleshoot common pitfalls when working with APExBIO's high-purity dihydroartemisinin in advanced biomedical research.

• Z-DEVD-FMK (SKU A1920): Reliable Caspase-3 Inhibition for Ro

  2026-07-15

  This article explores practical, scenario-driven solutions for apoptosis and neuroprotection workflows using Z-DEVD-FMK (SKU A1920), a cell-permeable, irreversible caspase-3 inhibitor from APExBIO. Through evidence-based Q&A, we address common experimental challenges and demonstrate how Z-DEVD-FMK enhances assay reproducibility, specificity, and workflow efficiency for biomedical researchers.

• AIBP-LRP2–HDL Axis Restricts Stemlike Capillary Expansion in

  2026-07-14

  This study uncovers how the AIBP-LRP2–mediated uptake of HDL restricts the expansion of CXCR4+ stemlike capillary endothelial cells during collateral vessel formation in ischemic conditions. The findings reveal a two-phase mechanism governing vascular remodeling and suggest new avenues for therapeutic revascularization.

• Comparative Gene Expression Reveals Conserved Claustrum Subd

  2026-07-14

  This study provides a comprehensive, cross-species analysis of gene expression within mammalian claustrum subdivisions, revealing evolutionarily conserved molecular and structural patterns. The findings enhance understanding of claustrum organization beyond traditional rodent models, supporting more accurate translational research in comparative neurobiology.

• Bradykinin (BA5201): Practical Guidance for Vasodilator Stud

  2026-07-13

  Bradykinin (SKU BA5201) is a potent endothelium-dependent vasodilator peptide optimized for research on vascular permeability, blood pressure regulation, and inflammation signaling. Its stability and purity make it suitable for controlled in vitro assays, but it is not designed for long-term solution storage or use in diagnostic settings. Researchers should follow strict handling protocols to maintain experimental reliability.

• Exosomal HMGB1 Drives Glomerular Endothelial Injury in Lupus

  2026-07-13

  This study reveals that podocyte-derived exosomes carrying HMGB1 are central mediators of glomerular endothelial cell injury in lupus nephritis, acting through the regulation of TRIM27. The findings highlight exosome-mediated podocyte–endothelial communication as a mechanistic driver of renal injury and suggest that targeting exosome biogenesis could offer new therapeutic opportunities.

• HMGB1-Loaded Exosomes Drive Glomerular Injury in Lupus Nephr

  2026-07-12

  This study reveals that podocyte-derived exosomes loaded with HMGB1 mediate glomerular endothelial cell injury in lupus nephritis through upregulation of TRIM27. By inhibiting exosome biogenesis or HMGB1 packaging, endothelial damage can be ameliorated, providing mechanistic insights for targeted interventions in autoimmune kidney disease.

• Optimizing IR-1061-Loaded Polystyrene Nanoparticles for Deep

  2026-07-10

  This study refines the design of over-1000 nm near-infrared fluorescent dye-loaded polystyrene nanoparticles, addressing the persistent challenges of dye aggregation and instability in vivo. By tuning nanoparticle polarity and solvent parameters specific to IR-1061 encapsulation, the authors deliver highly emissive, stable imaging probes suitable for dynamic deep tissue applications.

• 5-Azacytidine Induces ATR-Mediated DNA Damage in Myeloma Cel

  2026-07-09

  The reference study demonstrates that 5-azacytidine, a DNA methyltransferase inhibitor, triggers ATR-mediated double-strand DNA break responses and apoptosis in multiple myeloma cells, including those resistant to standard therapies. These findings provide mechanistic insight into its cytotoxic action and support its evaluation in combination regimens for refractory myeloma.

• Cyanidin Chloride: Translational Leverage in Oxidative Stres

  2026-07-09

  This thought-leadership article explores the mechanistic, experimental, and translational dimensions of Cyanidin Chloride, a high-purity anthocyanin polyphenolic antioxidant. Integrating recent evidence from psoriasis and oxidative stress models, it provides strategic guidance for translational researchers seeking robust and reproducible cell protection solutions. The narrative bridges mechanistic insight with actionable protocol recommendations, competitive positioning, and a forward-looking outlook for clinical translation.

7917 records 6/528 page Previous Next First page 上5页 678910 下5页 Last page